SciClone Pharmaceuticals Inc. (Nasdaq: SCLN) ended discussions with potential suitors and will remain an independent publicly traded company. The stock price plunged $2.76 to close at $10.50.
SciClone Pharmaceuticals ends merger talks
July 19, 2016 at 19:19 PM EDT
